Scientific Reference

Pinealon (EDR)

Evidence profile: Controlled human evidence

Pinealon (Glu-Asp-Arg/EDR) is a synthetic tripeptide bioregulator developed in Russia that demonstrates unique DNA-interaction capabilities for neuroprotection and cognitive enhancement. Research suggests benefits for traumatic brain injury recovery, age-related cognitive decline, and cellular aging processes through direct gene expression modulation. Studies have shown that Pinealon exerts neuroprotective effects through MAPK/ERK pathway modulation, reduced neuroinflammation, and enhanced NMDA receptor expression in hippocampal regions. Its ability to directly interact with DNA and influence gene expression makes it distinct from other peptide bioregulators.